A brief intervention to reduce anxiety in people with mild cognitive impairment and Alzheimer's disease and their caregivers
Randomized Clinical Trial of a Brief, Anxiety Intervention for Mild Cognitive Impairment/mild Alzheimer’s Disease and their Care Providers
This study is testing a short program to help reduce anxiety for people with mild cognitive impairment or Alzheimer's disease and their caregivers, making it easier for them to feel better and enjoy life more.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Florida State University NIH-funded |
| Lab location | 1 site (Tallahassee, United States) |
| Project ID | NIH-11023050 on NIH RePORTER |
What this research studies
This research investigates a brief intervention designed to help reduce anxiety in individuals with mild cognitive impairment (MCI) and Alzheimer's disease, as well as their caregivers. The study aims to address the high prevalence of anxiety symptoms in these populations, which can exacerbate cognitive decline and affect overall well-being. By focusing on anxiety sensitivity, the intervention seeks to provide a more efficient and accessible treatment option that does not rely heavily on cognitive abilities. Participants will engage in a structured program that aims to alleviate anxiety and improve quality of life.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with mild cognitive impairment or Alzheimer's disease, as well as their caregivers who experience significant anxiety.
Not a fit: Patients with severe cognitive impairment or advanced Alzheimer's disease may not benefit from this intervention due to the nature of their condition.
Why it matters
Potential benefit: If successful, this research could lead to effective strategies for managing anxiety in patients with MCI and Alzheimer's disease, enhancing their quality of life.
How similar studies have performed: Previous research has shown promise in using brief interventions to address anxiety in similar populations, suggesting potential for success in this approach.
Where this research is happening
Tallahassee, United States
- Florida State University — Tallahassee, United States (Active)
Researchers
- Principal investigator: Schmidt, Norman Brad — Florida State University
- Study coordinator: Schmidt, Norman Brad
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.